Utilidad clínica de las pruebas inmunológicas especializadas en reumatología en un hospital de segundo nivel de atención en México

Reumatología Clínica - Tập 3 - Trang 110-116 - 2007
Israel David Campos-González1, Martha Eva Viveros2, Mario H. Cardiel1,3,4
1Unidad de Investigación, Hospital General Dr. Miguel Silva, Morelia, Michoacán, México
2Laboratorio de Análisis Clínicos, Hospital General Dr. Miguel Silva, Morelia, Michoacán, México
3Servicio de Medicina Interna, Hospital General Dr. Miguel Silva, Morelia, Michoacán, México
4Servicio de Reumatología. Hospital General Dr. Miguel Silva. Morelia. Michoacán. México

Tài liệu tham khảo

Hepburn, 2001, LE cell, Rheumatology, 40, 826, 10.1093/rheumatology/40.7.826 Kavanaugh, 2000, Guidelines for clinical use of the antinuclear antibody test and test for especific autoantibodies to nuclear antigens, Arch Pathol Lab Med, 1, 71, 10.5858/2000-124-0071-GFCUOT Wikk, 2005, Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases, Scand J Rheumatol, 34, 260, 10.1080/03009740500202664 Anaya, 2005 Shojania, 2000, Rheumatology: 2. What laboratory tests are needed?, CMAJ, 162, 1157 Solomon, 2002, Evidence Based Guidelines for the use of immunologic tests: Antinuclear antibody testing, Arthritis Rheum, 47, 434, 10.1002/art.10561 Benito-Garcia, 2004, Guidelines for immunologic laboratory testing in rheumatic diseases: Anti-Sm and anti-RNP antibodies test, Arthritis Rheum, 51, 1030, 10.1002/art.20836 Viveros, 2005, Utilidad clínica de la determinación de anticuerpos antinucleares, anti DNA por ELISA, anticuerpos anticardiolipina, y anti-ENA en un hospital de segundo nivel de atención, Rev Mex Reumatol, 20, 75 Harrison, 2005 Malleson, 1997, Usefulness of antinuclear antibody testing to screen for rheumatic diseases, Arch Dis Child, 77, 299, 10.1136/adc.77.4.299 Gómez-Puerta, 2005, Long-term follow-up in 128 patients with primary antiphospholipid syndrome, Medicine (Baltimore), 84, 225, 10.1097/01.md.0000172074.53583.ea Lange, 1960, The significance of serum levels for the diagnosis and prognosis of acute and subacute glomerulonephritis and lupus erythematosus disseminatus, Ann Intern Med, 53, 636, 10.7326/0003-4819-53-4-636 Lai, 2005, Treatment for lupus nephritis: A revisit, Nephrology (Carlton), 10, 180, 10.1111/j.1440-1797.2005.00372.x Lyons, 2005, Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease, Ann N Y Acad Sci, 1050, 217, 10.1196/annals.1313.023 Ward, 1998, Laboratory testing for systemic rheumatic diseases, Postgrad Med, 103, 93, 10.3810/pgm.1998.02.310 Egner, 2000, The use of laboratory tests in the diagnosis of SLE, J Clin Pathol, 53, 424, 10.1136/jcp.53.6.424 Slater, 1996, Antinuclear antibody testing. A study of clinical utility, Arch Intern Med, 156, 1421, 10.1001/archinte.1996.00440120079007 Hahn, 1998, Mechanism of disease: Antibodies to DNA, N Engl J Med, 338, 1359, 10.1056/NEJM199805073381906 Tan, 1982, Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine, Adv Immunol, 33, 167, 10.1016/S0065-2776(08)60836-6 Kurien, 2006, Autoantibody determination in the diagnosis of systemic lupus erythematosus, Scand J Immunol, 64, 227, 10.1111/j.1365-3083.2006.01819.x Hochberg, 1997, Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 40, 1725, 10.1002/art.1780400928 Ravelli, 2005, Antiphospholipid syndrome, Pediatr Clin North Am, 52, 469, 10.1016/j.pcl.2005.01.001